Who invested in Visirna Therapeutics?
Visirna Therapeutics's investors include Vivo Capital.
Who invested in Visirna Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2022, from 1 source
- Latest round
- Seed, $60MApr 2022
- Investors
- 1
The rounds
- Apr 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Visirna Therapeutics
How much has Visirna Therapeutics raised?
Visirna Therapeutics has raised $60M across 1 round since 2022.
When did Visirna Therapeutics last raise?
Visirna Therapeutics's most recent round was a Seed of $60M in Apr 2022.
What was Visirna Therapeutics's biggest round?
Its most recent round, $60M in Apr 2022, is also its largest on record.
Who backed Visirna Therapeutics first?
Visirna Therapeutics's first round on record, in Apr 2022, was backed by Vivo Capital.
What stage is Visirna Therapeutics at?
Visirna Therapeutics's latest named round is a Seed, in Apr 2022.
Companies like Visirna Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.